Stanley Jacot Jr. - 30 May 2023 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role: Chief Executive Officer
Signature: Stanley E. Jacot, Jr., by Attorney-in-fact, Thomas J. Schaefer
Issuer symbol: RKDA
Transactions as of: 30 May 2023
Net transactions value: +$21,550
Form type: 4
Filing time: 30 May 2023, 18:24:20 UTC
Previous filing: 28 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RKDA	Common stock	Purchase	$21,550	+5,000		$4.31	5,000	30 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.